New Key Statistics Module, Z-Score and F-Score
NAS:AKRO Key Ratios
Market Cap $ M | 1,906.57 |
Enterprise Value $ M | 1,182.64 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 2.38 |
Price/Sales | -- |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -3.44 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -23.20 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -5.91 |
EV-to-EBITDA | -5.91 |
PEG | -- |
Shares Outstanding M | 69.43 |
Net Margin (%) | -- |
Operating Margin % | -- |
Pre-tax Margin (%) | -- |
Quick Ratio | 24.89 |
Current Ratio | 24.89 |
ROA % (ttm) | -27.92 |
ROE % (ttm) | -30.21 |
ROIC % (ttm) | -564.17 |
Dividend Yield % | -- |
Altman Z-Score | -- |
AKRO Number of Guru Trades
AKRO Volume of Guru Trades
Gurus Latest Trades with NAS:AKRO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:AKRO is held by these investors
Total 1
Akero Therapeutics Inc Insider Transactions
No Available Data
News about NAS:AKRO
Total 0- 1